Streetbeat News

Stock Prices

ARQT

In the last quarter, Arcutis Biotherapeutics (NASDAQ:ARQT) received 7 bullish ratings from analysts, with an average 12-month price target of $38.14, a decrease of 30.65% from the previous average price target of $55.00.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 6:00 pm

BALL

Over the past 3 months, 6 analysts have published their opinion on Ball (NYSE:BALL) stock, all of them being indifferent. The average price target is $58.17, implying an upside from the current price of $56.42. The current average has not changed from the previous average price target.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 6:00 pm

CAT

Caterpillar (NYSE:CAT) has outperformed the market over the past 20 years by 3.08% on an annualized basis, producing an average annual return of 10.79%. If an investor had bought $1000 of CAT stock 20 years ago, it would be worth $7,742.61 today.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 6:00 pm

RMD

ResMed (NYSE:RMD) has outperformed the market over the past 15 years, producing an average annual return of 14.92%. If an investor had bought $1000 of RMD stock 15 years ago, it would be worth $7,953.35 today.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 6:00 pm

DNLI

Denali Therapeutics (NASDAQ:DNLI) has received positive analyst ratings in the last quarter, with 2 bullish and 4 somewhat bullish ratings. The average price target for the stock is $79.83, a significant increase from the previous average of $53.50, indicating a potential upside from the current price of $24.02.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 6:00 pm

BSAQ

Shares of Black Spade Acquisition (BSAQ) have resumed trading.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 5:56 pm

ILMN

Stifel analyst Daniel Arias has reiterated a Buy rating on Illumina, Inc (NASDAQ:ILMN), but lowered the price target to $225 from $265. This comes after Illumina reported better-than-expected Q2 results, with revenue of $1.18 billion, up 1% Y/Y. However, Arias has reduced Q3 revenue estimates to $1.13 billion from $1.16 billion due to slowdown in consumables purchasing amid lower demand in China and instrument transition issues.

Portfolio Pulse from Nabaparna Bhattacharya

August 10, 2023 | 5:55 pm

DWAC

SPY

The Special Counsel has requested a January 2 trial date for the Trump election case. This news could potentially impact the stock prices of Digital World Acquisition Corp. (DWAC) and SPDR S&P 500 ETF Trust (SPY).

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 5:54 pm

IPAR

DA Davidson analyst Linda Bolton Weiser reiterated a Buy rating on Inter Parfums Inc (NASDAQ:IPAR) with a price target of $187. The company reported 2Q23 sales of $309 million, a 26% increase Y/Y. EPS of $1.09 was above the consensus. The strong performance was driven by both European and U.S. operations. The company raised the FY23 EPS guidance to $4.55 from $4.25 and maintained its sales guidance of $1.30 billion. IPAR shares are trading higher by 0.81% at $136.06.

Portfolio Pulse from Shivani Kumaresan

August 10, 2023 | 5:53 pm

BSAQ

Shares of Black Spade Acquisition (BSAQ) were halted on a circuit breaker due to a significant upside movement. The stock is now up by 77.5%.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 5:52 pm